Table II.
Efficacy and safety results for cryo-laser cryo-sclerotherapy (CLaCS) and foam
| Outcomes | No.a | CLaCS | Foam | Bilat | P valueb |
|---|---|---|---|---|---|
| Pigmentation on photo | 21 | 7 (33.3) | 5 (23.8) | 3 | .8906 |
| Colorimetry ΔE >1 | 21 | 9 (42.8) | 13 (61.9) | 7 | .1445 |
| Colorimetry ΔE >2 | 21 | 3 (14.2) | 7 (33.3) | 2 | .1094 |
| Colorimetry ΔE >2 FP III/IV | 20 | 2 (10) | 7 (35) | 2 | .0312 |
| Bruising D7 | 23 | 3 (13) | 9 (39.1) | 3 | .0156 |
| Micro thrombi/drainage | 23 | 3 (13) | 9 (39.1) | 2 | .0351 |
| Matting | 21 | 0 | 1 (4.7) | 0 | 1 |
| Scarring | 21 | 1 (4.7) | 0 | 0 | 1 |
| Redness/topic reaction | 23 | 2 (8.6) | 2 (8.6) | 2 | 1 |
Bilat, Patients that presented the outcome in both lower limbs; FP, Fitzpatrick skin type classification.
Data are presented as number (%).
a
No. varies due to participant loss to follow-up.
b
P value calculated using McNemar test.